An Apterostigma dentigerum fungus-growing ant collected in Gamboa, Panama, in her fungus garden. An ant-actinobacterium symbiosis yields an antibiotic that helps protect these gardens against predatory fungi while leaving the cultivated fungi unaffected. (Photo courtesy of Michael
Leaf-cutting, or attine, ants culture antibiotic-producing bacteria to defend their fungal gardens against predators. One of their selective antibiotics, an actinobacterially produced cyclic depsipeptide containing highly modified amino acids, was recently isolated and analyzed by Jon Clardy from the Harvard Medical School in Boston in collaboration with researchers there and at the University of Wisconsin in Madison. Their findings were reported online in the 29 March 2009 Nature Chemical Biology (doi: 10.1038/nchembio.159).
The newly characterized antimicrobial agent, named dentigerumycin in honor of Apterostigma dentigerum, the fungal-farming ant species that depend on its activity, "contains the unusual amino acids-piperazic acid, ␥-hydroxypiperazic acid, ␤-hydroxyleucine, and N-hydroxyalanineand has the molecular formula C 40 H 67 N 9 0 13 ," Clardy reports. Testing shows that dentigerumycin actively inhibits the fungal pathogen Escovopis while largely sparing the fungal cultivar of the ants. Independent of its use in ant colonies, dentigerumycin slows the growth of a drugresistant strain of Candida albicans, a human pathogen that is becoming increasingly resistant to a variety of antifungal drugs.
The chemically prolific actinobacteria involved in these multipartite symbioses are usually Pseudonocardia spp., which attine ants grow within specialized structures on their cuticles. "It may be a coevolutionary arms race between parasites like the virulent and highly evolved Escovopis fungus on the one hand and the remarkably successful ant-fungus-actinomycete mutualism on the other," says Cameron R. Currie, the microbial ecologist who discovered the ant-actinobacterial symbiosis more than a decade ago and is a member of the dentigerumycin discovery team.
The mutualism between attine ants and actinobacteria is perhaps the most thoroughly studied of all ant-bacterial relationships. Even so, the discovery of dentigerumycin marks the first characterization of a biochemical that strongly suppresses the growth of antgarden predatory fungi but not the basidiomycete fungus the ants cultivate for food.
Dentigerumycin is not the only chemical game in attine-ant town. "Pseudonocardia evolved a variety of small molecules over their long evolutionary history with fungal-farming ants, with different bacterial strains producing different antibiotics," Clardy says. "In fact, attine ants are walking pharmaceutical factories," adds Currie. "Each ant colony maintains a specific bacterial strain and can differentiate between it and foreign actinomycetes." Finding out how individual ant species and their distinct bacterial sidekicks cope with the specialized parasites that prey on their fungal crops is expected to yield an array of novel antimicrobial agents.
A bonus is that ant colonies also seem to be "miniature biofuel reactors," Cur-rie says. A single colony feeds their garden fungi up to 400 kg of leaves (dry weight) per year, and somehow the cellulose in those leaves is digested. Metagenomic studies of leaf-cutting ant colonies revealed the genetic signatures of cellulose-digesting fungi as well as many bacterial species also capable of breaking down this and other plant material. Transferring these metabolic capabilities to the laboratory has so far proved difficult, however. "The newly discovered bacterial and fungal enzymes may be efficient at digesting cellulose because they've evolved along with the ants, and a better understanding these long-term relationships may help us in our own attempts to break down plant biomass," Currie says. Thus, the scientists are now delving more deeply into the molecular evolution of these complex symbiotic communities, some of which are at least 50 million years old. "It's findings such as these that should fire the imagination of aspiring microbiologists," says Thomas Eisner, Professor Emeritus of Chemical Ecology at Cornell University in Ithaca, N.Y. "Think of the myriad of microbial interactions awaiting discovery and the body of knowledge that will be derived from characteriztion of their mediating chemicals. If I had to do it all over again, I'd go into microbial ecology." UPEC bacteria are notorious for causing persistent UTIs, with uroepithelial cells being the first targets within the urinary tract of these pathogens. Moreover, the host uroepithelial cells serve as an "internal quiescent reservoir," Bagli says. Noting that the extracellular matrix can be a potent mitogen to bladder muscle cells, he adds, "We became interested in whether the uroepithelial cell, obviously the first cell to come in contact with bacteria in the subsequent urinary tract infection cascade, may also undergo epigenetic changes in response to infection."
Marcia Stone
With a PCR-based assay, Bagli and his collaborators detected a sixfold increase in messenger RNA (mRNA) for DNA-N-methyltransferase-1 (DNMT-1) in vitro in human uroepithelial cells following infection with UPEC, compared to levels of that mRNA in uninfected cells. In turn, DNMT-1 activity is elevated more than 150-fold in such cells, according to the researchers. That enzyme catalyzes DNA methylation and is central to regulating gene expression in such cells. Thus, for example, the increase in DNA methylase activity leads to other changes in these cells, including a decrease in p16 -an important cellcycle regulator protein.
Those changes appear to disrupt not only p16 but also other cell cycle and DNA repair mechanisms within uroepithelial cells, leaving them more susceptible to persistent UPEC infections, according to Bagli. "We commonly deal with congenital abnormalities of the urinary tract in children
Plenty of Early Jockeying To Prepare H1N1 Flu Vaccines
In April and May as the H1N1 influenza outbreak spread from Mexico and the United States to much of the rest of the world, public health officials and vaccine manufacturers were actively planning for vaccines to curb that spread. Here are some highlights:
• GlaxoSmithKline in mid-May announced plans to make and stockpile a vaccine with adjuvant to protect against H1N1 influenza, pending availability of a seed virus from the World Health Organization (WHO); the company already has orders for 128 million doses from the governments of Britain, France, Belgium, and Finland.
• MedImmune, a subsidiary of AstraZeneca, began negotiating with officials at the Centers for Disease Control and Prevention (CDC) in Atlanta, Ga., late in April over developing a vaccine to protect against H1N1 flu.
• Food and Drug Administration (FDA) officials in May approved a new U.S.-based facility for producing Fluzone, the Sanofi Pasteur version of the influenza vaccine.
• Samuel Bogoch, chair of Replikins, Ltd., in London, U.K., in May said that its synthetic peptide H1N1 vaccine would be made available for testing and evaluation. that are at great risk for harboring and accelerating urinary tract infection," he says. "If there were some molecular test or state that could be determined from uroepithelial cells (commonly shed in simple urine samples) that would accurately help to predict and differentiate children at high or low risk for infection, then the often-difficult decision as to who might best benefit from surgical correction would become much clearer."
Sorting out who is more at risk of UTIs also could help to tailor antibiotic treatment or prophylaxis strategies, according to Bagli. A better ability to recognize at-risk groups would be particularly valuable when dealing with patients receiving organ transplants as well as others who are immunocompromised, including those receiving chemotherapy, premature infants, and those in intensive care units or other settings where the risk for infection is high.
"The increase in expression of a DNA methyltransferase is certainly intriguing and raises the possibility that methylation of host DNA promoter regions may occur in association with bacterial invasion," says pediatrician David Hunstad of Washington University in St. Louis, Mo., who specializes in infectious diseases. "If subsequent studies confirm an increase in DNA methylation, it will open a new area of investigation into epigenetic changes that permit UPEC to persist in the bladder epithelium, and perhaps shed light on the mechanisms by which UPEC might reemerge to cause recurrences."
Brian Hoyle
Brian (hoyle@square-rainbow.com) owns and runs Square Rainbow Ltd., a science writing and editing company. Whittaker's interest in the SARS spike protein cleavage sites stems from past efforts involving influenza viruses. These viruses contain hemagglutinin sites that are subject to host cleavage during infections. Those sites undergo changes as the viruses shift from being poorly pathogenic to highly pathogenic. This critical flu-based phenomenon inspired Whittaker and his collaborators to search for comparable cleavage site changes in SARS and closely related coronaviruses.
SARS Virus Spike Protein Second Cleavage Site Crucial for Species Shifts
For example, with guidance from the ProP 1.0 server, part of a database that predicts sites along proteins that are susceptible to proteolytic enzymes, they located a second cleavage site in infectious bronchitis virus (IBV), a laboratory-adapted strain of avian coronavirus and a subject for research since the 1940s. "The next logical connection was that IBV's unusual property of a second cleavage site may be present in other coronaviruses," Whittaker says. When they analyzed the structure of the SARS virus spike protein, they found a similar proteolytic cleavage site in the same position as in IBV.
The SARS spike protein within the coronavirus envelope regulates receptor binding through its S1 domain and fusion with the host membrane through its S2 domain, according to Whittaker and others. Proteolytic cleavage primes the spike protein in the SARS virus at the S1-S2 boundary, a phenomenon that was recognized several years ago. The second cleavage site in the S2 domain, which the Cornell scientists call S2Ј, apparently acts in concert with the other site, enabling infectivity and fusion of the virus with the host cell membrane. Cleaving the viral protein at the S1-S2 site promotes cleavage at the S2Ј position, triggering membrane fusion. Details appear in the April 7, 2009 Proceed-
Persistent Cytomegalovirus Infection an Apparent Risk Factor for Hypertension
Cytomegalovirus (CMV) infections can help to elevate blood pressure, in part by stimulating expression of renin in a dose-dependent manner, according to Clyde Crumpacker of Harvard Medical School in Boston, Mass., and his collaborators there and at nearby Tufts University School of Medicine. Thus, when mice were infected with CMV, their blood pressure rose, as did renin and angiotensin II expression in blood-vessel endothelial cells carrying the virus. CMV also induced renin expression in human blood-vessel endothelial cells, reinforcing the idea that persistent infection with this virus is a risk factor for hypertension, the Boston researchers point out. Further, although CMV does not appear to cause atherosclerosis, it does boost blood pressures that are associated with this condition and with high-cholesterol diets. Details appear in the may 15 PLoS Pathogens. Changes along that second cleavage site somehow allow the virus to jump species, in some cases from animals to humans, according to Whittaker. "It's still a hypothesis," he says. "The finding of a second cleavage site opens up lots of theories and lays a foundation to rethink how coronaviruses work in general." He and his collaborators are searching for similar sites in other coronaviruses.
SARS emerged in 2002-2003, causing severe respiratory illnesses in more than 8,000 individuals and killing 10% of them. Another coronavirus that is equivalent in virulence to SARS eventually will emerge, Whittaker predicts. "It will probably be a different coronavirus from a different animal next time."
The findings reported by Whittaker and his collaborators are "a carefully executed and beautiful study of the multi-step proteolysis needed for coronavirus entry," says virologist Tom Gallagher at Loyola University Medical Center in Maywood, Ill. Moreover, their results confirm that entry by SARS following spike protein cleavage is more complicated than earlier assumed. Echoing Whitaker, Gallagher predicts that other zoonotic coronaviruses of equal severity to SARS can be expected to adapt to and infect humans. "If you know the proteases necessary for infection," he says, "there's an opportunity to inactivate them with drugs and limit infection."
Carol Potera
Carol Potera is a freelance writer in Great Falls, Mont. Taylor Glacier is the source of one of the most unusual natural anomalies in Antarctica-namely, Blood Falls, a sluggish outflow from the glacier that is ferruginous, meaning it contains iron that turns reddish-brown, the color of blood, when exposed to atmospheric oxygen. The source of this seeping subglacial seawater likely persisted for the past 1.5 million years or more. Radar images of what lies beneath the glacier surface reveal an 80-meter subglacial basin of unknown depth. Microorganisms within that basin are isolated from organic input or oxygen. Thus, they grow in the dark and in brine, according to Mikucki and her collaborators. Moreover, the metabolism of the microbial consortium, based on analysis of samples from the outflow at Blood Falls, depends on a catalytic sulfur cycle, she says.
Blood-Like Seepage at Glacier Brims with Metabolic Oddities
"Despite the fact that many of the microorganisms are related to known marine microorganisms phylogenetically, their metabolic strategy is quite different," Mikucki says. "We know that sulfur below the glacier is cycled by biology as evidenced by the functional gene analysis and the sulfur and oxygen isotopic measurements we did, yet sulfate is not reduced to sulfide. Instead, the sulfate is regenerated, or cycled, catalytically. This is quite unusual and has not been observed in natural systems before." "The importance of the microbial ecosystem described in the April [17] issue of Science is in the details of the iron and sulfur biochemistry and the possible analogy to the Canfield Thus, the conditions during the Snowball Earth episode could be much like those now found at Blood Falls in the Antarctic. In both cases, thick ice lowers organic matter that microorganisms produce.
The Mikucki "observation that Fe can persist in a system even with high sulfate concentrations . . . would imply that something other than sulfate concentration (or, in my way of thinking, sulfate flux to the oceans, which isn't exactly the same) changes could promote a flip between iron-rich and sulfidic ocean conditions," Canfield says. "[She and her collaborators] argue that organic matter availability may be just the trigger. I think this is an interesting idea and may have relevance in some systems like the one explored in their paper. However, . . . the flux of organic carbon to the deep ocean far exceeds the flux of iron, so, for the Mikucki model to work, the primary productivity of the Precambrian oceans must have been orders of magnitude less than it is now. There's nothing in the geologic record to suggest that this was true." "Energetics would favor iron reduction as organic matter became limited," Mikucki says. "Our results demonstrate that the absence of sulfate is not required for a system to accumulate Fe(II). The brine below the Taylor Glacier is ferruginous despite significant concentrations of sulfate, thus organic matter availability is an important factor in the 'choice' of respiratory pathway." Barry E. DiGregorio Barry E. DiGregorio is a freelance writer in Middleport, N.Y. Nonetheless, skepticism persists, as is evident not only from the forthcoming NAS review but also during the plenary session, "The Science behind the 'Anthrax Letter' Attack Investigation," convened as part of the 7th ASM Biodefense & Emerging Diseases Research Meeting, held in Baltimore, Md., last February, and during the news conference that followed. "Everybody is frustrated by the lack of closure," says plenary session participant Paul Keim of Northern Arizona University (NAU) in Flagstaff.
Questions Linger over Science behind Anthrax Letters
Soon after the World Trade Center in New York, N.Y., and the Pentagon outside Washington, D.C., were attacked on September 11, 2001, letters containing spores of Bacillus anthracis were sent to members of the news
Scent Sensors Are New Target for Repellents To Curb Insect Vector-Borne Diseases
Ionotropic receptors (IRs) in antennae of insects are previously unrecognized components of the olfactory system of insects, including fruit flies and mosquitoes, and thus a potential target for repellents that could help in controlling insect-borne diseases, according to Howard Hughes Medical Institute investigator Leslie Vosshall of Rockefeller University in New York, N.Y. Uncovering the link between IRs and insect behavior could prove crucial for manipulating smell and thereby interfering with how insects transmit infectious diseases, she said during a meeting of the Congressional Biomedical Research Caucus in mid-May. Mosquitoes rely on the sense of smell to find humans by cuing in on human sweat and carbon dioxide in breath, and this behavior is key to transmission of malaria and other infectious diseases to humans through blood feeding. media and Congress. Contact with those letters led to 22 cases of anthrax, including five deaths, along with cleanup measures that, for example, cost the U.S. Postal service $1.2 billion to decontaminate several of its facilities, according to Jason Bannan of the FBI Chemical-Biological Sciences Unit in Quantico, Va., and a participant in the ASM plenary session. "FDA never had a case like this before," he says.
No spore-containing letter was recovered from the first attack that led to the death of a photojournalist in Boca Raton, Fla. However, investigators recovered spores as part of a granular, white powdery material from an envelope involved in the second incident. Bannan describes it as a "crude prep," in part because it also contained Bacillus subtilis. Additional material from other letters to thenSenator Tom Daschle (D-SD) and to Senator Patrick Leahy (D-VT) in October 2001 appeared "more refined," was "beige" instead of white, and contained no spores other than B. anthracis.
The FBI quickly requested outside microbiologists to help in analyzing those materials. The available "research assays . . . didn't meet forensic standards," says Keim who, with his collaborators at NAU, worked closely with the FBI, as did other outside groups of microbiologists and investigators with other expertise. Moreover, efforts to develop such assays were complicated by the strictly clonal biology that B. anthracis follows during replication.
Those facts soon led microbial and molecular forensics investigators into conducting genomics-level analyses, according to Jacques Ravel, now at the University of Maryland School of Medicine and Institute for Genome Sciences in Baltimore, Md. A more conventional phenotypic analysis supplemented those genomic-level efforts, leading another group of microbiologists at USAMRIID, who were working with the FBI and others on the anthrax investigation, to take advantage of distinct B. anthracis "morphotypes" that could be observed on growth plates. Those morphotypes vary not only by colony appearance but also in sporulation efficiencies and in telltale mutations at a rare "hot spot" within the otherwise stable genome of this species.
That information became the basis for a PCR screening assay for B. anthracis specimens that then was validated at Commonwealth Biotechnologies (CB) in Richmond, Va., and the Midwest Research Institute in Palm Bay, Fla., to ensure that such testing could meet forensics standards applied by U.S. courts. By 2007, the "highly specific" PCR assay identified several samples during a "blinded" analysis that included "seized materials," Bannan says. Ultimately, the PCR-based analysis along with other information from the criminal side of the investigation indicated that the anthrax-causing specimens from the 2001 letters derived from stocks produced several years earlier at USAM-RIID for an aerosol challenge in anthrax vaccine studies, he says.
Based on that and other information from more conventional lines of evidence, FBI investigators concluded that Ivins, who died following a drug overdose in July 2008, produced spores from those stocks for the 2001 anthrax attacks.
Despite that painstaking analysis and the unequivocal conclusions put forth by FBI officials, doubts linger over some matters that are mainly scientific as well as others that intersect with the broader thrust of the investigation. For instance, none of the microbiologists, including Bannan and similar specialists at FBI, was privy to other evidence, including lab records from USAMRIID, that their FBI colleagues collected. "I know nothing of that information," he says. "I'm a microbiologist, and was not involved in the seizure of evidence."
Other lingering questions focus on more purely scientific issues, some of them pertaining to how the lethal bacteria were handled. For example, US-AMRIID held B. anthracis in aqueous suspensions, not as spores. Presumably, the spores sent via letters were produced in at least two separate batches, contaminated with B. subtilis at least once, but when and how remain unknown. "We don't know the process used," Bannan says. "We never found the equivalent B. subtilis at USAMRIID in any of the evidence that we had." Efforts to trace the source of that bacterial contaminant "didn't lead anywhere," adds Keim.
Early reports suggested that the
Sludge Bacteria Prove Apt at Degrading Cholesterol
Gordonia cholesterolivorans, a bacterial species isolated from sewage sludge, can actively degrade cholesterol in such settings but might be used to make or modify novel types of cholesterol derivatives for medical applications, according to Oliver Drzyzga and his collaborators at the Universidad Complutense de Madrid, Spain. Because some Gordonia species are human pathogens, it is unlikely that these bacteria will ever be used directly to control cholesterol levels in humans, Drzyzga points out. "We are trying to work out exactly how G. cholesterolivorans metabolizes cholesterol so that we can identify and construct metabolically engineered strains that are more rapid and effective in breaking down cholesterol." Details appear in the May International Journal of Systematic and Evolutionary Microbiology.
Volume 4, Number 7, 2009 / Microbe Y 313 spores were "weaponized," possibly with "silica." However, later analysis determined that the spores were not coated with silica, although silicon was found within-not outside-the coat of spores used in the attacks, according to Joseph Michael of Sandia National Laboratory in Albuquerque, N.M. About two-thirds of the spores contain that silicon "signature," he says. Attempts to grow fresh spores with silicon to determine whether it also would locate within the spore coat led to "variable" results, Bannan adds. "We don't understand why there is a varying degree of silicon from one batch to another." Other questions regarding physical properties of the spores similarly remain unexplained. Asked whether the spores were milled, Bannan points out that B. anthracis spores in letters went through rollers in automated postal sorting equipment that subjected them to high pressures. "It's a high-energy process, and [spore] plumes went up 30 feet [about 10 m] from the mail sorters," he says. How those spores looked beforehand or whether they were pulverized after being dried and before being inserted into envelopes is not known.
